U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07431840) titled 'Immune Defense Protein Impact On Respiratory Immune Outcomes' on Feb. 19.
Brief Summary: The primary goal of this study is to observe the impact of the IDP(R) Supplement on the duration and severity of upper respiratory symptoms in older individuals during the cold and flu season. Secondary aims include observing the product's effect on rescue medication use, quality of life, and overall tolerability. This is conducted as a consumer-driven, decentralized observational clinical research study in adults aged 60 or older, using self-reported measures and questionnaires completed at home via the Chloe App.
Study Start Date: Dec. 05, 20...